Oncology Imaging Systems (OIS) is pleased to announce the appointment of Jess Fuller and Mike Holroyd to the company's Board of Directors. Both long-standing and valued members of the OIS team, Jess and Mike bring a wealth of experience and dedication to their new roles.
Throughout their tenure with the company, Jess and Mike have helped to shape and drive the company forward while embodying the company's core values of patient focus, integrity, reliability and transparency. As Directors, they will play a key role in promoting the continued growth and evolution of OIS.
Jess Fuller is appointed as Managing Director
Jess Fuller, newly appointed Managing Director, joined OIS in 2010 with a background in financial administration. She was later promoted to Business Manager in 2015. Throughout her time at OIS, Jess has been involved in many areas of the business, including finance, logistics, quality, regulatory, marketing and operations. Jess has been instrumental in developing company policy and strategy, implementing best practice and optimising operational efficiency.
Speaking about her appointment, Jess said, "I am honoured to take on the role of Managing Director at OIS. It is a privilege to work with such a strong and passionate team, and I am excited to continue our plans to grow and develop the company."
Mike Holroyd is appointed as Sales Director
Mike Holroyd has been appointed Sales Director, succeeding his former role as Sales Manager. With a wealth of experience in sales, particularly in the field of Radiotherapy and Medical Physics, Mike brings a unique perspective and expertise to his new role.
During his 17-year career, Mike has been active in various sales roles, 12 of which were in the field of Radiotherapy and Medical Physics. He joined the OIS sales team in 2014 and was quickly promoted to Sales Manager. Throughout his tenure, he has played a vital role in helping to grow and shape the company into what it is today.
Speaking about his appointment, Mike said, "It is a very exciting time, and I am delighted to be appointed as a Director of OIS. I look forward to continuing the development of the company with a strong focus on our patient-first ethos."
A few words from OIS Founding Director, Steve Imber
Jess and Mike join Steve Imber, who after 23 years as Managing Director takes on the role of Founding Director and Chairman, on the company’s Board of Directors. Commenting on the appointments, Steve said, "Having worked with Jess for nearly 13 years and Mike for nine, I am really pleased and excited about these well-earned appointments. Our success is a direct reflection of their commitment to this company, our customers and wider industry. I wish them every success as they continue to grow and bring the best out of the team."
We're confident that Jess and Mike will continue to provide a valuable impact on the company, and we’re excited to see what the next chapter brings.